A carregar...
KRAS and BRAF Mutation Detection: Is Immunohistochemistry a Possible Alternative to Molecular Biology in Colorectal Cancer?
KRAS genotyping is mandatory in metastatic colorectal cancer treatment prior to undertaking antiepidermal growth factor receptor (EGFR) monoclonal antibody therapy. BRAF V600E mutation is often present in colorectal carcinoma with CpG island methylator phenotype and microsatellite instability. Curre...
Na minha lista:
| Publicado no: | Gastroenterol Res Pract |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4422999/ https://ncbi.nlm.nih.gov/pubmed/25983749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/753903 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|